Spasticity is considered an important neural contributor to muscle hypertonia in children with
cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum …

Many neurological and musculoskeletal diseases impair movement, which limits people's
function and social participation. Quantitative assessment of motion is critical to medical …

Objective The results of previous research into exercise interventions for children with
cerebral palsy are inconsistent. The aim of this study is to assess the effectiveness of such …

In a typical clinical gait analysis, the gait patterns of pathological individuals are commonly
compared with the typically faster, comfortable pace of healthy subjects. However, due to …

Treatment of Cerebral Palsy and Motor Delay is a highly practical, easy-to-read resource for
all paediatric practitioners and students working with the developmental abilities and …

Background Intra-class correlation coefficients (ICCs) provide a statistical means of testing
the reliability. However, their interpretation is not well documented in the orthopedic field …

The minimally clinically important difference (MCID) is an important concept for interpreting
the results of clinical research. This paper proposes a rationale for defining an MCID for the …

Understanding the lower limb kinematic, kinetic, and electromyography (EMG) data
interrelation in controlled speeds is challenging for fully assessing human locomotion …

Background: Single-event multilevel surgery is considered the standard of care to improve
gait and functioning of children with spastic diplegic cerebral palsy. However, the evidence …

Background. Strength training programs for children with cerebral palsy (CP) showed
inconclusive evidence for improving walking, despite improvements in strength. Recent …